No article text was recorded for this version.
variant-specific protective thresholds
Version 1 of 129 papers34 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
- Blog: Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
- Blog: Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial
- Blog: Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
- Blog: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
- Blog: Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
- Blog: Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
- Blog: P-2051. Assessing SARS-CoV-2 Correlates Protection from Exposed Household Members: A Prospective Cohort Study (AB-PROTECT Study)
- Blog: Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
- Blog: In-person schooling and associated COVID-19 risk in the United States over Spring Semester 2021
- Blog: ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study
- Blog: Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection
- Blog: Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
- Blog: Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
- Blog: Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
- Blog: SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
- Blog: Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns
- Blog: In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
- Blog: Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine
- Blog: Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
- Blog: Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities
- Blog: Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
- Blog: Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
- Blog: Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
- Blog: Predicting the mutational drivers of future SARS-CoV-2 variants of concern
- Blog: Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination
- Blog: Evidence for antibody as a protective correlate for COVID-19 vaccines
- Blog: Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers
- Blog: Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants
History & citation
Current · Permanent link
- This direction split from humoral-cellular immunity gap (55% overlap)
- This direction split from Shifting Immune Correlates in an Evolving Viral Landscape (59% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_variant_specific_protective_thresholds_1f58a449,
title = {variant-specific protective thresholds},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/variant-specific-protective-thresholds/rdr_1f58a44907514f3490a35cf994496c74},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_variant_specific_protective_thresholds_1f58a449_v1,
title = {variant-specific protective thresholds},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/variant-specific-protective-thresholds/rdr_1f58a44907514f3490a35cf994496c74/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}